Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 Treatment

NCT04351295 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT04351295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04351295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 Treatment
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Completed
Start date
April 20, 2020
Completion date
September 28, 2020
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid